Newsletter | January 13, 2022

01.13.22 -- ePRO In A Data-Driven World

ePRO Use And Technology Design In Oncology Development

Learn how electronic clinical outcome assessments (eCOA) and emerging connected technologies are effectively bridging the gap between traditional models and the future of oncology drug development.

Practical Considerations For Patient-Focused Data Collection In Oncology Trials

Read how new initiatives for data collection reinforce the importance of the patient’s voice, acknowledge the limitations of traditional approaches, and build on the lessons that emerge from each new study.

Thoughtful Design In eCOA Development To Enhance Patient Experience

eCOAs can enhance the patient experience, keeping in mind three important considerations: focus on the most critical data, focus on the patient when designing eCOAs, and focus on the user experience.

Device Strategy For eCOA: BYOD Or Provisioned?

Which device is better for collecting eCOAs — a patient’s own device, known as bring-your-own-device (BYOD), or a vendor-provisioned device (PD)? The short answer is, “It depends.” By asking the right questions, and understanding and preparing for all the variables, you can help a sponsor successfully implement the modality that increases patient compliance while minimizing missing data and risks to data integrity throughout the life of a study, even a long-term study.

eCOA For Oncology Studies

The use of eCOA in oncology clinical studies is on the rise, but not without implementation challenges. That’s why YPrime’s eCOA solution was designed with oncology trials in mind — to minimize response burden while providing flexibility and creative data collection solutions that promote compliance and withstand regulatory scrutiny.

Request Information